uveitis - Articles and news items

FDA approves adalimumab for the treatment of non-infectious uveitis

Industry news / 1 July 2016 / Victoria White, Digital Content Producer

Adalimumab is now the only FDA-approved non-corticosteroid therapy available for adults with non‑infectious intermediate, posterior and panuveitis…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+